Time to Buy Great-West Lifeco Stock?

Great-West Lifeco reported solid Q1 2022 results, but GWO stock is still down for the year.

Great-West Lifeco (TSX: GWO) just reported solid Q1 2022 earnings results. The shares have been on a downward trend over the past three months, and investors are wondering if GWO stock is now undervalued.

calculate and analyze stock

Image source: Getty Images

Great-West Lifeco operations

Great-West Lifeco is a financial services holding company based in Winnipeg. The asset portfolio includes life insurance, health insurance, retirement, and investment services, along with asset management and reassurance operations.

The company’s subsidiaries serve 33 million customers in Canada, the United States, and Europe, operating under the brands Canada Life, Empower, Putnam Investments, and Irish Life.

Great-West Lifeco is a part of the Power Corp group of companies.

Great-West Lifeco Q1 2022 earnings

Great-West Lifeco generated Q1 2022 base earnings of $809 million for the quarter, up 9% from the same period last year. On a per-share basis, Great-West Lifeco reported base earnings of $0.87 compared to $0.80. Europe and the United States delivered better results compared to the first three months in 2021. Canadian operations saw earnings dip. Weak equity markets and a strong Canadian dollar led to a 4% dip in assets under administration.

Great-West Lifeco generated a Q1 return on equity of 14.7%. That was up from 13.6% on a year-over-year basis.

Great-West Lifeco remains well capitalized with a LICAT ratio 119%. This is near the high end of its target level and comfortably above government requirements.

Dividends

Income investors like Great-West Lifeco for its generous distribution and attractive dividend yield. The company raised the payout by 12% late last year. The current quarterly distribution of $0.49 per share provides an annualized yield of 5.6% at the time of writing.

Great-West Lifeco is targeting a dividend-payout ratio of 45-55% of base earnings. If earnings growth continues along the 9% range for the year, investors should see another decent increase for 2023.

In the event that things get ugly and global equity markets continue to correct in the coming months, the dividend should still be safe.

Outlook

The jump in life insurance claims due to the pandemic should drop in 2022 and 2023, as more people build immunity through vaccines and exposure to the virus. Regarding the wealth and asset management side of the business, weak equity markets could put added pressure on results in the near term.

On the positive side, upward movements in interest rates should benefit the insurance businesses by enabling them to earn better returns on the cash they have to set aside to cover potential claims.

Great-West Lifeco continues to make strategic acquisitions to drive growth. The company recently closed its US$3.55 billion purchase of Prudential’s full-service retirement business in the United States. The deal, made by the Empower subsidiary, adds 4,300 workplace savings plans and US$314 billion in assets under management. The Empower division in the United States should get an additional US$325 million in after-tax earrings by the end of 2023. Earnings per share accretion is targeted at 8-9% on a run-rate basis by the end of next year. As a result, Empower’s contribution to Great-West Life’s earrings is expected to grow by 30% by the end of 2023.

Should you buy Great-West Lifeco stock?

The stock looks undervalued today at $35 per share. Great-West Lifeco traded as high as $41 in February. Management expects to deliver 8-10% annual base earnings per share growth over the medium term and 14-15% base return on equity. That’s pretty good guidance.

Investors searching for solid dividend stocks for a portfolio focused on passive income might want to consider buying Great-West Lifeco on the pullback.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Andrew Walker owns shares of Power Corp.

More on Dividend Stocks

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

Why I Love VDY and Its Generous 3% Dividend Yield

This popular Canadian dividend ETF pays a decent monthly yield, charges low fees, and has historically beat the market.

Read more »

Investor wonders if it's safe to buy stocks now
Dividend Stocks

Enbridge Stock: Is It Still a Top Passive Income Pick for Retirees?

Enbridge's attractive 5.7% dividend yield, improving cash flows, and massive growth backlog make it a compelling passive income stock for…

Read more »

earn passive income by investing in dividend paying stocks
Dividend Stocks

$10,000 in Your TFSA: 2 Stocks to Buy for Passive Income

Given their well-established businesses, reliable cash flows, consistent dividend payouts, and high yields, these two Canadian stocks are ideal for…

Read more »

Colored pins on calendar showing a month
Dividend Stocks

What $40,000 in a Dividend Portfolio Could Pay Without Selling Shares

A $40,000 portfolio can help with recurring bills even if you leave every share in the account. Here’s what three…

Read more »

diversification and asset allocation are crucial investing concepts
Dividend Stocks

How Many Enbridge Shares You Need for $1,000 in Dividends

Enbridge pays $3.88 a share. At $68.59, you need 258 shares, about $17,696, to earn $1,000 a year in annual…

Read more »

dreaming of financial success
Dividend Stocks

Passive Income: Is Enbridge Stock Still a Buy for Its Dividend Yield?

Enbridge’s resilient cash flow profile, solid payout history, and a growing earnings base strengthen its appeal as a high yield…

Read more »

boy in bowtie and glasses gives positive thumbs up
Dividend Stocks

3 Blue-Chip Dividend Stocks Every Canadian Should Own

These Canadian blue-chip dividend stocks are known for consistently paying and increasing their dividends year after year.

Read more »

up arrow on wooden blocks
Dividend Stocks

Standout Canadian Blue-Chip Stocks to Own in 2027

Explore Canadian blue-chip stocks for 2027, with Canadian National, Fortis and Manulife offering distinct paths to earnings growth and dividend…

Read more »